Dose of Reality

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART V: BIG PHARMA’S DEBUNKED INNOVATION RHETORIC

Jan 1, 2024

Big Pharma Discredited Its Own Bogus Rhetoric on Research and Development in Read More

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART IV: TAX AVOIDANCE SCHEMES AND KICKBACKS

Dec 29, 2023

Big Pharma’s Tax Avoidance Schemes and Use of Kickbacks to Boost Profits Read More

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART III: BIG PHARMA’S ANTI-COMPETITIVE TACTICS

Dec 28, 2023

Exploring the Cost of Big Pharma’s Egregious Abuse of the Patent System With Read More

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART I: BIG PHARMA’S EGREGIOUS PRICING PRACTICES

Dec 26, 2023

Take a Look Back on Big Pharma’s Year of Price Hikes And Skyrocketing Launch Read More

DOSE OF REALITY: EXPERT WITNESS HIGHLIGHTS BIG PHARMA’S EGREGIOUS PRICING OF NEW WEIGHT LOSS DRUGS

Dec 19, 2023

Senate Testimony Underscores Staggering Potential Cost of High-Priced Weight Read More

DOSE OF REALITY: BIG PHARMA’S INNOVATION TAP DANCE HAS INDUSTRY TRIPPING OVER ITS OWN RHETORIC

Dec 12, 2023

Big Pharma Continues Pushing Myth That Solutions to Lower Rx Prices Will Read More

DOSE OF REALITY: VOTERS WANT CANDIDATES TALKING ABOUT DRUG PRICES AND FOCUSED ON HOLDING BIG PHARMA ACCOUNTABLE

Dec 6, 2023

KFF Survey Finds Americans Want White House Contenders Talking Rx Prices, Read More

DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS OVER $40 BILLION IN JUST ONE YEAR

May 23, 2023

New Analysis Highlights Urgency to Hold Big Pharma Accountable for Egregious Read More

DOSE OF REALITY: BIG PHARMA TAX AVOIDANCE PRACTICES COME UNDER SCRUTINY IN SENATE FINANCE HEARING

May 12, 2023

Report Finds Big Pharma Games the System to Avoid Paying U.S. Taxes While Read More

DOSE OF REALITY: SENATORS MUST HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS INSULIN PRICING PRACTICES

May 9, 2023

Lawmakers Have Opportunity to Grill Big Pharma Executives on Tactics Like Read More